National Peroxide Ltd

National Peroxide Limited, formerly known as NPL Chemicals Limited, submitted a certificate to the BSE Limited on October 8, 2026, in terms of regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, received from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, registrar and share transfer agent of the company for the quarter ended September 30, 2026, confirming the acceptance or rejection of securities received for dematerialization and their listing on stock exchanges.

National Peroxide Limited informed the BSE Limited that the trading window for the company's securities will be closed for all designated persons and their immediate relatives from October 01, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half year ending September 30, 2026.

National Peroxide Limited, formerly known as NPL Chemicals Limited, will hold a board meeting on August 12, 2026, to consider and approve the revised audited financial results for the quarter and financial year ended March 31, 2026, and the revised audited financial statements for the financial year ended March 31, 2026, as well as the unaudited financial results for the quarter ended June 30, 2026.

National Peroxide Limited, formerly known as NPL Chemicals Limited, announced on August 2, 2026, the deferment of its board meeting previously scheduled for August 3, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026; the company will inform the BSE Limited of the revised date in due course, and the trading window for the company’s securities will remain closed for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the unaudited financial results are declared.

National Peroxide Limited, formerly known as NPL Chemicals Limited, will hold a board meeting on Monday, August 03, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited.

National Peroxide announced that the Board of Directors of the Company at its meeting held on 30 April 2026, inter alia, have recommended the final dividend of Rs 7 per equity Share (i.e. 70%) , subject to the approval of the shareholders.

Net profit of National Peroxide reported to Rs 7.93 crore in the quarter ended March 2026 as against net loss of Rs 6.49 crore during the previous quarter ended March 2025. Sales rose 16.26% to Rs 85.68 crore in the quarter ended March 2026 as against Rs 73.70 crore during the previous quarter ended March 2025. For the full year,net profit reported to Rs 11.04 crore in the year ended March 2026 as against net loss of Rs 2.25 crore during the previous year ended March 2025. Sales rose 0.99% to Rs 289.71 crore in the year ended March 2026 as against Rs 286.87 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales85.6873.70 16 289.71286.87 1 OPM %17.38-3.19 -10.775.30 - PBDT15.95-2.74 LP 35.8118.03 99 PBT10.67-7.82 LP 15.02-2.08 LP NP7.93-6.49 LP 11.04-2.25 LP Powered by Capital Market - Live

National Peroxide will hold a meeting of the Board of Directors of the Company on 30 April 2026.

Net profit of National Peroxide reported to Rs 1.83 crore in the quarter ended December 2025 as against net loss of Rs 1.52 crore during the previous quarter ended December 2024. Sales rose 11.15% to Rs 69.09 crore in the quarter ended December 2025 as against Rs 62.16 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales69.0962.16 11 OPM %10.125.18 - PBDT7.573.19 137 PBT2.36-2.00 LP NP1.83-1.52 LP Powered by Capital Market - Live

National Peroxide has revised the meeting of the Board of Directors which was scheduled to be held on 28 January 2026. The meeting will now be held on a later date.Powered by Capital Market - Live